It’s official! #SetPointSystem is now FDA approved for the treatment of rheumatoid arthritis (RA) in adults who are not adequately managed by, or who cannot tolerate, existing advanced RA therapies. See the release: #Rheumatology #RheumTwitter #MedTwitter.

Big ambition takes big investment and audacious leadership -- that's why we're excited to announce today that we've secured $140 million in private financing, and welcomed key new executives to our leadership team and board of directors. Read more:

RT @EricTopol: Controlling the immune system and inflammation through stimulating the vagus nerve. FDA approval of an implant for refractor….

We're so pleased to see this coverage of the FDA approval of the #SetPointSystem in the @nytimes! Read the full story to learn more about the life-changing power of neuroimmune modulation:. Safety info in bio. #Rheumatology #RheumTwitter #MedTwitter.

We were honored to have our national surgical PI @RMarkRichardson present RESET-RA results during the Plenary Session at #AANS25. Data presented highlight SetPoint System’s potential as a first-of-its-kind neuroimmune modulation treatment for RA. #TheSetPointAdvantage

Nice story by @NPR about how neuroimmune modulation is unlocking new possibilities for treating autoimmune diseases like #RA. #TheSetPointAdvantage. The SetPoint System is limited by U.S. law to investigational use only.

We're excited to announce late-breaking data from the RESET-RA study at @ACRheum #ACR24 supporting the SetPoint System's potential as a first-of-its-kind neuroimmune modulation treatment for rheumatoid arthritis (#RA). Learn more in our press release:

RT @KevinJTraceyMD: Congrats to @SetPointMed for proving the inflammatory reflex benefits patients with RA ! Now onto other autoimmune cond….

We're thrilled to announce positive topline results from our RESET-RA clinical study for rheumatoid arthritis (#RA)!. The Setpoint System is limited by United States law to investigational use only. Read the full announcement:. #TheSetPointAdvantage.

We're happy to share that, following the recent Breakthrough Device Designation, Setpoint's neuroimmune modulation platform for the treatment of MS has now been accepted into the FDA's TAP Pilot!.#TheSetPointAdvantage. Learn more in our press release:

🎉 Big news incoming:. SetPoint’s novel neuroimmune modulation platform received Breakthrough Device Designation from the FDA for multiple sclerosis (MS) treatment!. Learn more here:. #MSAwarenessWeek #TheSetPointAdvantage.

SetPoint Medical’s co-founder @KevinJTraceyMD spoke with @katiecouric about the innovative field of neuroimmune modulation and our ongoing RESET-RA trial investigating this novel treatment option for RA patients. Check it out: 

Thanks to their efforts, and the efforts of many, many more, we continue to make good progress towards wrapping up enrollment in this consequential study this year. Stay tuned! And learn more at

We’re grateful for the dedication and support of our RESET-RA study investigators in South Florida like Dr. Justin Sporrer, as well as Dr. Norman Gaylis, Dr. Guillermo Valenzuela, Dr. Jonathan Greer, Dr. Amiel Tokayer & Dr. Frank Vrionis.

RT @KevinJTraceyMD: Data accumulates targeting the Vagus Nerve inflammatory reflex is giving hope for future options beyond biologics and J….

We're working to prove the value of neuroimmune modulation in #rheumatology, aiming to bring new options for patients. "This is the brand-new field of neuromodulation for the treatment of autoimmune disease,” explains our CMO. Check out the latest buzz:

We are thankful for the support of seasoned investors who possess deep industry knowledge and a passion for improving outcomes for patients with chronic medical conditions, and look forward to furthering our clinical and regulatory goals toward FDA approval of our novel therapy.

Big day for @SetPointMed! Just announced: $145M in new financing to support the development of our therapeutic platform; includes $80M in equity financing co-led by @NorwestVP & Viking Global Investors, as well as $65M credit facility with @RunwayGrowth.

RT @NorwestVP: Join us in welcoming @SetPointMed to the Norwest portfolio! The company is poised to transform the lives of millions with ch….

RT @NorwestVP: 🤝Read our investment team’s blog to learn more about how @SetPointMed is changing the game for #autoimmune disease treatment….